Health unicorn Alan raises €480m Series G round led by Prosus

A evolving shift in Technology emerges as Health unicorn Alan raises €480m Series G round led by Prosus. Market analysts are evaluating the regional implications for US positioning. Healthtech startup Alan has raised a €480m Series G funding round, valuing the digital insurer and healthcare platform at €5.5bn.Dutch investment giant Prosus led the round, alongside existing backers Index Ventures and Teachers' Venture Growth, as well as new investor Dara Holdings.Founded in 2016, Alan began as a digital health insurance provider but has expanded into a broader healthcare platform combining insurance, care and prevention services.Sector focus: Technology This development has significant implications for Technology, potentially influencing competitive dynamics, investment patterns, and strategic priorities across the sector. AdvertisementAlan said it reached more than €800m in annual recurring revenue in the first quarter of 2026, representing 53% year-on-year growth. Market ImplicationsForward-Looking IndicatorsContinued consolidation expected in the sectorIncreasing focus on digital transformation and innovationGrowing importance of ESG considerations Expert Commentary“Healthcare presents one of the most significant global opportunities for AI-led transformation,” said Fahd Beg, head of investments at Prosus. Looking AheadFor complete details on this development, refer to the original report from Sifted (Financial Times). Frequently Asked Questions